Notice 16 Jun 2025 collaboration, government, nih, health, research, licensing, biotechnology, influenza

💡Licensing Opportunities for Government-Owned Influenza Inventions

The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

Learn More
Notice 1 May 2025 fda, medical devices, influenza, regulatory compliance, health

🧪FDA Notice on Reagents for Detection of Specific Novel Influenza A Viruses

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection associated with Agency guidance on reagents for detection of specific novel influenza A viruses.

Learn More